Back to Compound Explorer

Hypoxoside

Preliminary

Mechanism of Action

Hydrolysed by intestinal beta-glucosidase to rooperol (the active catechol norlignan aglycone); hypoxoside itself is pharmacologically inert but serves as a bioavailable prodrug form. Rate and extent of conversion varies with intestinal microbiota composition, explaining inter-individual variability in clinical response.

Research Notes

Hypoxoside has been demonstrated to convert reliably to rooperol in vivo in human pharmacokinetic studies. Orally administered hypoxoside achieves measurable rooperol plasma levels within 1–2 hours. Standardisation of raw corm preparations to hypoxoside content (0.3–1.2% w/w dried corm) is feasible by HPLC. The prodrug approach avoids premature catechol oxidation that would render rooperol inactive before absorption.

Found In 1 Herb

3D Molecular Structure

Norlignan glucoside (prodrug)
Drag to rotate · Click atoms to explore

Hypoxoside

Norlignan glucoside (prodrug)Plant polyphenols with antioxidant and estrogenic activity

Representative pattern: C₄H₂NO

Atoms
Carbon
Oxygen
Nitrogen
Hydrogen

Live Research

Open on PubMed

This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.